New drug and better measurement tools aim to tackle severe valley fever
Disease control
Not yet recruiting
This phase 2 trial tests an experimental antifungal drug called olorofim in people with a severe, body-wide form of Valley Fever (disseminated coccidioidomycosis) that has not responded to standard treatments. The study also evaluates new questionnaires about symptoms and quality…
Phase: PHASE2 • Sponsor: F2G Ltd • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC